Small-cap pharma stock jumps 22% in two days after THESE bulk deals

Balaxi Pharmaceuticals shares surged 22% after bulk transactions, opening at ₹57 and peaking at ₹62.58. While operational revenue grew 20.6%, net profit dropped 55.2%, signaling difficulties for the company despite its expanding presence in emerging markets.